- Home
- DLTH vs SER Comparison
DLTH vs SER Comparison
Compare DLTH & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLTH
- SER
- Stock Information
- Founded
- DLTH 1989
- SER 2017
- Country
- DLTH United States
- SER United States
- Employees
- DLTH N/A
- SER N/A
- Industry
- DLTH Clothing/Shoe/Accessory Stores
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- DLTH Consumer Discretionary
- SER Health Care
- Exchange
- DLTH Nasdaq
- SER Nasdaq
- Market Cap
- DLTH 62.6M
- SER 53.5M
- IPO Year
- DLTH 2015
- SER 2018
- Fundamental
- Price
- DLTH $1.88
- SER $5.63
- Analyst Decision
- DLTH Hold
- SER Strong Buy
- Analyst Count
- DLTH 1
- SER 1
- Target Price
- DLTH $2.75
- SER $11.00
- AVG Volume (30 Days)
- DLTH 37.9K
- SER 10.2K
- Earning Date
- DLTH 05-29-2025
- SER 05-08-2025
- Dividend Yield
- DLTH N/A
- SER N/A
- EPS Growth
- DLTH N/A
- SER N/A
- EPS
- DLTH N/A
- SER N/A
- Revenue
- DLTH $626,629,000.00
- SER $51,000.00
- Revenue This Year
- DLTH N/A
- SER N/A
- Revenue Next Year
- DLTH N/A
- SER N/A
- P/E Ratio
- DLTH N/A
- SER N/A
- Revenue Growth
- DLTH N/A
- SER N/A
- 52 Week Low
- DLTH $1.58
- SER $3.81
- 52 Week High
- DLTH $4.54
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- DLTH 50.46
- SER 52.25
- Support Level
- DLTH $1.71
- SER $5.27
- Resistance Level
- DLTH $1.96
- SER $6.61
- Average True Range (ATR)
- DLTH 0.13
- SER 0.51
- MACD
- DLTH 0.03
- SER -0.03
- Stochastic Oscillator
- DLTH 64.71
- SER 35.53
About DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.